First report of safety and efficacy of daratumumab in 2 cases of advanced immunoglobulin light chain amyloidosis

Taimur Sher; Brooke Fenton; Adnan Akhtar; Morie A. Gertz

doi:10.1182/blood-2016-06-722496

First report of safety and efficacy of daratumumab in 2 cases of advanced immunoglobulin light chain amyloidosis

Taimur Sher
, Brooke Fenton
, Adnan Akhtar
, Morie A. Gertz

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1987-1989
Number of pages	3
Journal	Blood
Volume	128
Issue number	15
DOIs	https://doi.org/10.1182/blood-2016-06-722496
State	Published - Oct 13 2016

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2016-06-722496

Cite this

@article{d112a7ee94554b72be82fd9c8c47a248,

title = "First report of safety and efficacy of daratumumab in 2 cases of advanced immunoglobulin light chain amyloidosis",

author = "Taimur Sher and Brooke Fenton and Adnan Akhtar and Gertz, \{Morie A.\}",

year = "2016",

month = oct,

day = "13",

doi = "10.1182/blood-2016-06-722496",

language = "English (US)",

volume = "128",

pages = "1987--1989",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "15",

}

TY - JOUR

T1 - First report of safety and efficacy of daratumumab in 2 cases of advanced immunoglobulin light chain amyloidosis

AU - Sher, Taimur

AU - Fenton, Brooke

AU - Akhtar, Adnan

AU - Gertz, Morie A.

PY - 2016/10/13

Y1 - 2016/10/13

UR - https://www.scopus.com/pages/publications/84991646684

UR - https://www.scopus.com/pages/publications/84991646684#tab=citedBy

U2 - 10.1182/blood-2016-06-722496

DO - 10.1182/blood-2016-06-722496

M3 - Letter

C2 - 27543437

AN - SCOPUS:84991646684

SN - 0006-4971

VL - 128

SP - 1987

EP - 1989

JO - Blood

JF - Blood

IS - 15

ER -

First report of safety and efficacy of daratumumab in 2 cases of advanced immunoglobulin light chain amyloidosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this